GLP-1 use in Peritoneal Dialysis (PD) patients
Unique considerations for PD patients, including glucose absorption from dialysate.
Written by Professor Mohammed Mahdi Althaf
Overview
Peritoneal dialysis involves using a glucose-based fluid in the abdomen. This glucose can contribute significantly to daily calorie intake, which must be accounted for when using GLP-1 medications.
This article is general information and is not individual medical advice. Treatment decisions are made at a face-to-face consultation.
More in Weight loss on dialysis (HD/PD)
Book your first consultation
Booking done on Professor Althaf's clinic page and clicking here will take you there